Prediction Case File
YouTubeEvaluation Complete

Corbus Pharmaceuticals Holdings Stock Prediction and Forecast [CRBP]

1 extracted signal · 1 resolved · 0 still active

StockInvest.us profile imageStockInvest.usIndependent analyst profile
Source published
29 Aug 2025, 03:10 UTC
Recorded by Tahlil Plus
18 May 2026, 20:23 UTC
Video preview for Corbus Pharmaceuticals Holdings Stock Prediction and Forecast [CRBP]
Source overview

AI-generated source summary

Corbus Pharmaceuticals Holdings, based on moving averages, presents a positive forecast. Short-term averages are above the long-term average. Downward corrections, support lies at $9.86 and $9.13. A breakdown of these values will issue sell signals. A buy signal from the 3-month Moving Average Convergence Divergence (MACD). Sell signal a pivot top on Wednesday, August 27, further fall is indicated until a new bottom pivot has been found. Volume fell along with the price, which is technically positive. CRBP stock has medium daily movements and medium risk. Short term: Buy long term: Sell. Trading levels with accumulated volume: Resistance at $10.47, Support at $8.67. Vitals : Risk is classified as medium and the weekly volatility is 6.84%. Insiders Buy 1938540 shares and sell 138404 shares. The analysis suggests a buy and expect CRBP to open higher by approximately $0.233 to start trading at $10.13.

AI-generated summary based on the source content.

Live evaluation

Signal outcomes at a glance

Evaluation Complete
Signals
1
Extracted from this source
Open
0
Still being tracked
Successful
0
Resolved successfully
Failed
1
Resolved unsuccessfully
Other
0
Cancelled, invalid or excluded
Resolved success
0%
1 resolved; open signals omitted
Extracted intelligence

Signals in this source

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. First prediction resolved

    The first evaluable outcome in this case reached a terminal result.

  3. Case evaluation completed

    All evaluable predictions in this case reached terminal outcomes.

  4. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  5. Market predictions extracted

    1 eligible signal linked to this case.

  6. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

Analyst snapshot

StockInvest.us

Platform-wide history, separate from this source evaluation.

Reliability
53.4
Tracked signals
1779
Historical success
42.8%
View full analyst profile →
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.

Continue the evidence trail